1. Nguyen HT, Sheu TG, Mishin VP et al (2010) Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother 54(9):3671–3677. https://doi.org/10.1128/AAC.00581-10
2. World Health Organization. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses. https://www.who.int/teams/global-influenza-programme/laboratory-network/quality-assurance/antiviral-susceptibility-influenza. Accessed 4 July 2022
3. Meijer A, Rebelo-de-Andrade H, Correia V et al (2014) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. Antivir Res 110:31–41. https://doi.org/10.1016/j.antiviral.2014.07.001
4. Takashita E, Meijer A, Lackenby A et al (2015) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antivir Res 117:27–38. https://doi.org/10.1016/j.antiviral.2015.02.003
5. Hurt AC, Besselaar TG, Daniels RS et al (2016) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015. Antivir Res 132:178–185. https://doi.org/10.1016/j.antiviral.2016.06.001